Financial Calendar for Zealand Pharma in 2018

Copenhagen, November 30, 2017 - Zealand Pharma ("ZEAL") announces the following dates for the company's planned financial reporting in 2018:

7 March                               Full year announcement and Annual Report 2017       
16 May                                Interim report for the first three months of 2018
16 August                            Interim report for 1st half 2018
15 November                      Interim report for the first 9 months of 2018

Zealand's Annual General Meeting will be held on April 19, 2018.

For further information, please contact:

Mats Blom, Executive Vice President and Chief Financial Officer
Tel.: +45 31 53 79 73, e-mail: mabl@zealandpharma.com

About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim as well as a pipeline of internal product candidates focusing on specialty gastrointestinal and metabolic diseases.

Zealand is based in Copenhagen (Glostrup), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or follow us on Twitter @ZealandPharma or LinkedIn.